Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older.
Shoroq M AltawalbehAngela R WateskaMary Patricia NowalkChyongchiou J LinLee H HarrisonWilliam SchaffnerRichard K ZimmermanKenneth J SmithPublished in: Applied health economics and health policy (2023)
US societal cost of racial pneumococcal disease disparities in persons aged ≥ 50 years is substantial. Successful pneumococcal vaccination policy and programmatic interventions to mitigate these disparities could decrease costs and improve health.